Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A Prospective, Multicenter Surveillance Study for Adverse Events Associated with Hematopoietic Stem Cell Infusion: Analysis of Pediatric and Low Body-Weight Recipients

Blood (2018) 132 (Supplement 1): 2105.

https://doi.org/10.1182/blood-2018-99-118328

Published: 2018

Journal Articles

Management of Perioperative Anticoagulation in Patients with VWD

Mario Von Depka, MD PhD, Carsten Detering, MSc, Stefanie Döpke, Mahnaz Ekhlasi-Hundrieser, PhD

Blood (2015) 126 (23): 1100.

https://doi.org/10.1182/blood.V126.23.1100.1100

Published: 2015

Journal Articles

Factor VIII Dosing and Preventive Efficacy in Obese Patients with Hemophilia (BMI ≥30 kg/m 2 ) – a Post-Hoc Sub-Analysis of the guardian™ Trials

Michael Recht, MD PhD, Steven R. Lentz, MD PhD, Silva Zupancic-alek, Irina Matytsina, Andrea Landorph, Trine Saugstrup

Blood (2014) 124 (21): 1503.

https://doi.org/10.1182/blood.V124.21.1503.1503

Published: 2014

Journal Articles

Clinical Comparison of Incidences, Risk Factors and Outocmes of Chronic Graft-Versus-Host Desease in Unrelated Cord Blood Transplantation and Unrelated Bone Marrow Transplantation

Yuki Asano-Mori, MD PhD, Atsushi Wake, MD PhD, Kosei Kageyama, MD, Daisuke Kaji, MD, Kazuya Ishiwata, MD, Shinsuke Takagi, MD PhD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Naoyuki Uchida, MD PhD, Koji Izutsu, Akiko Yoneyama, MD PhD, Shigeyoshi Makino, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2014) 124 (21): 1172.

https://doi.org/10.1182/blood.V124.21.1172.1172

Published: 2014

Journal Articles

18 f-FDG (FDG) PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL). A Preliminary Retrospective Analysis of Children's Oncology Group (COG) AHOD0031

Steve Y Cho, MD, Kathleen M McCarten, MD, Lu Chen, PhD, Debra L Friedman, MD, MS, Suzanne L Wolden, MD, Kathryn Karolczuk, Cindy L Schwartz, MD, MPH, Kara M Kelly, MD

Blood (2012) 120 (21): 1530.

https://doi.org/10.1182/blood.V120.21.1530.1530

Published: 2012

Journal Articles

Prophylactic Foscarnet and Suppression of Pre-Engraftment Immune Reaction Are Essential to Overcome the Development of HHV-6 Encephalitis From the Experience of 496 Adult Cord Blood Transplants in Toranomon Hospital

Yuki Asano-Mori, MD, PhD, Kazuya Ishiwata, MD, Taichi Ikebe, MD, Hikari Ota, MD, Aya Nishida, MD, Masanori Tsuji, MD, Hisashi Yamamoto, MD, Naoyuki Uchida, MD, PhD, Koji Izutsu, MD, PhD, Akiko Yoneyama, MD, PhD, Shigeyoshi Makino, MD, PhD, Shuichi Taniguchi, MD, PhD

Blood (2012) 120 (21): 461.

https://doi.org/10.1182/blood.V120.21.461.461

Published: 2012

Journal Articles

Biological Activity of Low-Molecular-Weight Heparin Increases Over 9 Days in Patients Treated for Acute Venous Thromboembolism.

Job Harenberg, Kai Bauer, Claudia Abletshauser

Blood (2009) 114 (22): 4176.

https://doi.org/10.1182/blood.V114.22.4176.4176

Published: 2009

Journal Articles

A Case-Control Study on the Role of an Antiviral Treatment with Interferon and Ribavirin after Conventional Chemotherapy in Diffuse Large B-Cell Lymphomas with Hepatitis C Virus (HCV) Infection

Roberto Guariglia, Stefano Luminari, Amalia De Renzo, Emilio Iannitto, Matteo Dell’Olio, Samantha Pozzi, Teresa Pierri, Lucia D’Amato, Antonio Traficante, Stefano Sacchi, Pellegrino Musto

Blood (2008) 112 (11): 3054.

https://doi.org/10.1182/blood.V112.11.3054.3054

Published: 2008

Journal Articles

An Exercise Training Programme Produces Significant Improvements in Quality of Life (QoL), Muscle Strength and Cardiorespiratory Function in Patients with Myeloma.

Lara J. Groeneveldt, BSc, Rachel Garrod, PhD, Kwee L. Yong, MD, Flora Dangwa, RGN, Andrew P. Jewell, PhD, Ken van Someren, PhD, Neil Rabin, MD, Lisa Nicholls, RGN, Shirley P. D’Sa, MD

Blood (2007) 110 (11): 3323.

https://doi.org/10.1182/blood.V110.11.3323.3323

Published: 2007

Journal Articles

GlycoPEGylated Filgrastim XM22 Demonstrates Dose-Dependent Activity in Comparison to Pegfilgrastim in a Dose-Escalating Study in Healthy Volunteers after Body-Weight Dependent Single Dose.

Heinz Lubenau, PhD, Rolf Pokorny, MD, Luis Lopez-Lazaro, MD, Peter Bias, MD, Bruce Wallin, MD, Walter Hinderer, PhD, Anne-Katrin Maly, Michael Seiberling, MD

Blood (2007) 110 (11): 4081.

https://doi.org/10.1182/blood.V110.11.4081.4081

Published: 2007

Journal Articles

GlycoPEGylated Filgrastim XM22 Fixed Dose Demonstrates Similar Activity in Comparison to Pegfilgrastim in Healthy Volunteers after Single Administration.

Heinz Lubenau, PhD, Rolf Pokorny, MD, Luis Lopez-Lazaro, MD, Peter Bias, MD, Bruce Wallin, MD, Walter Hinderer, PhD, Anne-Katrin Maly, Michael Seiberling, MD

Blood (2007) 110 (11): 4082.

https://doi.org/10.1182/blood.V110.11.4082.4082

Published: 2007

Journal Articles

I.V. Busulfan Given Based on Body Weight in Combination with Cyclophosphamide in Children: Pharmacokinetic and Clinical Results of a Myeloablative, Reduced-Toxicity Conditioning Regimen for Allogeneic Stem Cell Transplantation.

Helene Esperou, MD, Bénédicte Neven, MD, Karima Yakouben, MD, Claire Galambrun, MD, Françoise Méchinaud, MD, Catherine Paillard, MD, Pierre Bordigoni, MD, Hamadi Zouabi, MD, Laurent Nguyen, PharD, Gérard Michel, MD, Gilles Vassal, MD PhD

Blood (2006) 108 (11): 5131.

https://doi.org/10.1182/blood.V108.11.5131.5131

Published: 2006

Journal Articles

Self-Managed Long-Term Low-Molecular-Weight Heparin Therapy Compared with Usual-Care Anticoagulation for the Treatment of Patients with Proximal Venous Thrombosis: Harm Associated with Thrombocytopenia.

Russell D. Hull, MBBS, MSc, Graham F. Pineo, MD, Rollin F. Brant, PhD, for the LITE Trial Investigators

Blood (2005) 106 (11): 4142.

https://doi.org/10.1182/blood.V106.11.4142.4142

Published: 2005

Journal Articles

A New IV Busulfan Fixed Dosing as Part of BuMel or BuCy Conditioning Regimens: A Pharmacokinetic/Pharmacodynamic Study in Pediatric Patients Undergoing Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.

Gilles Vassal, MD, PhD, Hélène Esperou, MD, Dominique Valteau-Couanet, MD, Jean Claude Gentet, MD, François Doz, MD, Françoise Méchinaud, MD, Claire Galambrun, MD, Alain Fischer, MD, Hamadi Zouabi, MD, Laurent Nguyen, Pharm D, Gérard Michel, MD

Blood (2005) 106 (11): 5200.

https://doi.org/10.1182/blood.V106.11.5200.5200

Published: 2005

Journal Articles

A New Busulfan Fixed Dosing for Conditioning before Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children with Malignant and Non-Malignant Diseases: Pharmacokinetics, Toxicity and Clinical Outcomes.

Gérard Michel, MD, Dominique Valteau-Couanet, MD, Hélène Esperou, MD, Jean Claude Gentet, MD, François Doz, MD, Françoise Méchinaud, MD, Claire Galambrun, MD, Alain Fischer, MD, Hamadi Zouabi, MD, Christian Puozzo, PhD, Gilles Vassal, MD, PhD

Blood (2005) 106 (11): 1758.

https://doi.org/10.1182/blood.V106.11.1758.1758

Published: 2005

Journal Articles

Self-Managed Long-Term Low-Molecular-Weight Heparin Compared with Usual-Care Anticoagulation for Patients with Proximal Venous Thrombosis: Harm Associated with Bleeding!.

Russell D. Hull, MBBS, MSc, Graham F. Pineo, MD, Rollin F. Brant, PhD, for the LITE Trial Investigators

Blood (2005) 106 (11): 901.

https://doi.org/10.1182/blood.V106.11.901.901

Published: 2005

Journal Articles

Evaluation of Baseline Body-Weight Dosing of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy in Patients with Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma (NHL).

Gregory Wiseman, MD, Peter Conti, MD, Katie Vo, Russell J. Schilder, MD, Paul Foster, MD, Leo I. Gordon, MD, Christos Emmanouilides, MD, Dan Silverman, MD, Thomas E. Witzig, MD, Arturo Molina, MD

Blood (2004) 104 (11): 2634.

https://doi.org/10.1182/blood.V104.11.2634.2634

Published: 2004

NARROW

A Prospective, Multicenter Surveillance Study for Adverse Events Associated with Hematopoietic Stem Cell Infusion: Analysis of Pediatric and Low Body-Weight Recipients

Management of Perioperative Anticoagulation in Patients with VWD

Factor VIII Dosing and Preventive Efficacy in Obese Patients with Hemophilia (BMI ≥30 kg/m 2 ) – a Post-Hoc Sub-Analysis of the guardian™ Trials

Clinical Comparison of Incidences, Risk Factors and Outocmes of Chronic Graft-Versus-Host Desease in Unrelated Cord Blood Transplantation and Unrelated Bone Marrow Transplantation

18 f-FDG (FDG) PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL). A Preliminary Retrospective Analysis of Children's Oncology Group (COG) AHOD0031

Prophylactic Foscarnet and Suppression of Pre-Engraftment Immune Reaction Are Essential to Overcome the Development of HHV-6 Encephalitis From the Experience of 496 Adult Cord Blood Transplants in Toranomon Hospital

Biological Activity of Low-Molecular-Weight Heparin Increases Over 9 Days in Patients Treated for Acute Venous Thromboembolism.

A Case-Control Study on the Role of an Antiviral Treatment with Interferon and Ribavirin after Conventional Chemotherapy in Diffuse Large B-Cell Lymphomas with Hepatitis C Virus (HCV) Infection

An Exercise Training Programme Produces Significant Improvements in Quality of Life (QoL), Muscle Strength and Cardiorespiratory Function in Patients with Myeloma.

GlycoPEGylated Filgrastim XM22 Demonstrates Dose-Dependent Activity in Comparison to Pegfilgrastim in a Dose-Escalating Study in Healthy Volunteers after Body-Weight Dependent Single Dose.

GlycoPEGylated Filgrastim XM22 Fixed Dose Demonstrates Similar Activity in Comparison to Pegfilgrastim in Healthy Volunteers after Single Administration.

I.V. Busulfan Given Based on Body Weight in Combination with Cyclophosphamide in Children: Pharmacokinetic and Clinical Results of a Myeloablative, Reduced-Toxicity Conditioning Regimen for Allogeneic Stem Cell Transplantation.

Self-Managed Long-Term Low-Molecular-Weight Heparin Therapy Compared with Usual-Care Anticoagulation for the Treatment of Patients with Proximal Venous Thrombosis: Harm Associated with Thrombocytopenia.

A New IV Busulfan Fixed Dosing as Part of BuMel or BuCy Conditioning Regimens: A Pharmacokinetic/Pharmacodynamic Study in Pediatric Patients Undergoing Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.

A New Busulfan Fixed Dosing for Conditioning before Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children with Malignant and Non-Malignant Diseases: Pharmacokinetics, Toxicity and Clinical Outcomes.

Self-Managed Long-Term Low-Molecular-Weight Heparin Compared with Usual-Care Anticoagulation for Patients with Proximal Venous Thrombosis: Harm Associated with Bleeding!.

Evaluation of Baseline Body-Weight Dosing of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy in Patients with Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma (NHL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only